Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Julphar
US Army
Boehringer Ingelheim
Accenture
US Department of Justice
Healthtrust
Cantor Fitzgerald
Daiichi Sankyo

Generated: October 22, 2017

DrugPatentWatch Database Preview

Lab Hra Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for LAB HRA PHARMA, and what generic alternatives to LAB HRA PHARMA drugs are available?

LAB HRA PHARMA has one approved drug.

There are five US patents protecting LAB HRA PHARMA drugs.

There are fifty-three patent family members on LAB HRA PHARMA drugs in twenty-six countries.

Summary for Applicant: Lab Hra Pharma

International Patents:53
US Patents:5
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► Subscribe ► Subscribe
Lab Hra Pharma
ELLA
ulipristal acetate
TABLET;ORAL022474-001Aug 13, 2010ABRXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for LAB HRA PHARMA drugs

Drugname Dosage Strength Tradename Submissiondate
ulipristal acetate
Tablets30 mg
ELLA
8/13/2014

Non-Orange Book Patents for Lab Hra Pharma

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,616,073Method for on-demand contraception► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Lab Hra Pharma Drugs

Country Document Number Estimated Expiration
Canada2745084► Subscribe
Colombia6400186► Subscribe
Japan5951480► Subscribe
World Intellectual Property Organization (WIPO)2010119029► Subscribe
Mexico2011006106► Subscribe
Russian Federation2542779► Subscribe
Slovenia2365800► Subscribe
World Intellectual Property Organization (WIPO)2010066749► Subscribe
Russian Federation2011127989► Subscribe
Japan2016188232► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Harvard Business School
Merck
Farmers Insurance
Healthtrust
Cantor Fitzgerald
Fuji
Covington
Cipla
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot